Early-fasting mimetics may protect the heart by burning glutamine supplied by muscle
In old mice with delayed feeding, a fasting mimetic may sustain heart energy using muscle-derived glutamine, potentially depleting muscle over repeated cycles. Failure of alternative fuel to restore protection despite verified recovery of energy flow in an isolated heart would reject this explanation.
Stage of verification
- Hypothesis published2026-10-06
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
The biological function description is being prepared
Lens
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Enzyme
GLS1
An enzyme that uses glutamine and can compete with its use in the hexosamine pathway
Where this hypothesis actsCardiomyocytes during delayed feeding under an early-fasting mimetic
Hypotheses on this target 5
Inhibition4
Activation
Lower level
Higher level
Replacement
Protection from degradation
Cofactor removal
Synthesis suppression
Function preservation
What is proposed
Inhibition
Selectively suppress GLS1 to test whether protection depends on glutamine oxidation
With whatControlled genetic model
HowInducible tissue-specific suppression; test alternative oxidizable fuel in an isolated heart while maintaining GLS1 blockade
Possible result
Expected ATP decline before injury and loss of protection, with possible rescue by alternative fuel
From the recordИзбирательное подавление сердечной GLS1 снижает образование АТФ раньше появления повреждений и устраняет защиту.
Metabolite or ion
Glutamine
A fuel whose carbon contributes to oxidative metabolism
Where this hypothesis actsExport from skeletal muscle to the heart during delayed feeding and repeated mimetic exposure
Hypotheses on this target 1
Supplementation
Accelerated excretion
Composition restoration
What is proposed
Offset glutamine fuel consumption to limit depletion of muscle reserves
With whatSmall molecule
HowCombine the early-fasting signal with fuel replacement; test alternative oxidizable fuel in an isolated heart
Possible result
Possible preservation of cardiac protection and muscle reserves across repeated cycles
From the recordНовый вариант миметика должен сочетать ранний сигнал голодания с замещением расходуемого топлива
Enzyme
AMPK
AMP-activated protein kinase
Where this hypothesis actsLysosomal signaling under an early-fasting mimetic
Hypotheses on this target 1- Inhibition
- Activation1
- Lower level
- Higher level
- Replacement
- Protection from degradation
- Cofactor removal
- Synthesis suppression
- Function preservation
What is proposed
Activation
Activate lysosomal AMPK to initiate the early-fasting signal
With whatSmall molecule
HowUse aldometanib as the proposed mimetic
Possible result
Possible support of target-tissue function through glutamine oxidation
From the recordальдометаниб активирует лизосомную АМФ-активируемую протеинкиназу (AMPK)
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Keeping the heart working when feeding is delayed may come at the expense of muscle. The unexpected move is to pair a substance that imitates the body’s early response to fasting with replacement fuel, because the proposed protection depends on drawing fuel from muscle reserves. This is a hypothesis generated by the pipeline, not a measured demonstration of that trade-off or of longer life.
- Aldometanib, the proposed drug used to imitate early fasting, activates an energy-sensing enzyme at the cell’s recycling compartments.
- Adding a phosphate chemical group to the protein identified as PDZD8 is proposed to increase glutaminase 1, or GLS1, the enzyme that converts glutamine into glutamate, another protein building block, in heart muscle cells.
- Skeletal muscle supplies glutamine that reaches the heart when feeding is delayed.
- The heart burns glutamine-derived carbon through its fuel-processing reactions to support production of adenosine triphosphate, or ATP, the molecule that powers cellular work.
- The additional energy is proposed to preserve heart function, so interrupting glutamine supply or its use removes protection.
- Repeated demand depletes muscle protein if breakdown supplies exported glutamine faster than later protein synthesis replaces it.
- Replacement fuel paired with the fasting signal is proposed to preserve heart protection while reducing the draw on muscle reserves.
A house keeps its stove burning by taking wood from its own floorboards. Delivering other firewood could preserve both the heat and the floor.
Where the picture breaks: Muscle can rebuild its protein, and glutamine can serve purposes other than fuel. Detecting its movement into the heart would therefore not establish either net muscle loss or energy production as the cause of protection.
- Master questionstep 01 of 04
Imitating beneficial processes already used by the body could offer new ways to extend life.
Rests on: The supplied goal explicitly seeks new hypotheses about which bodily processes to reproduce, which interventions might reproduce them, and why they might extend life.
Stated in the chain - Goal pillarstep 02 of 04
An artificial signal that imitates a bodily process should match both the resources available and the body’s actual need for that response.
Rests on: The goal seeks beneficial imitations of bodily processes, but does not explicitly make resource availability and physiological need conditions of benefit.
AssumptionThe pillar assumes that matching the induced response to available resources and actual need is a necessary design principle for obtaining the intended benefit.
- Gap questionstep 03 of 04
A substance that imitates early fasting might preserve energy in one tissue by consuming glutamine supplied by muscle; interrupting that supply might remove protection when feeding is delayed.
Rests on: The preceding pillar raises the general problem of matching a signal to its resource supply, but does not identify muscle-derived glutamine as the resource supporting protection.
LeapNeither the preceding text nor the screened sources supplies evidence that the induced protection depends on glutamine moving from muscle to the protected tissue and being consumed there.
- Hypothesisstep 04 of 04
The heart is proposed to preserve its function by burning glutamine supplied by skeletal muscle, the muscle that moves the body. Repeated responses could deplete muscle protein if its breakdown supplies that glutamine and subsequent rebuilding falls short, motivating a fasting mimic paired with replacement fuel.
Rests on: The preceding question explicitly supplies the proposed dependence on muscle glutamine and the predicted loss of protection when that exchange is interrupted. The endpoint develops this into a heart-specific mechanism and distinguishing predictions; those additions are proposals rather than established findings.
Stated in the chain
What is carried, and what is not. Of the seven mechanism links listed here, one has direct partial support from a screened source: Tissue & Cell (2026, S1) reports aldometanib activating the energy-sensing enzyme and increasing removal of damaged cellular energy-producing structures, with reduced heart-cell injury, but does not establish the proposed glutamine route or muscle cost. Physiological Genomics (2006, S2), available here only as an abstract, reports altered fuel metabolism in genetically modified mice; it establishes neither muscle-to-heart glutamine transfer nor this protective mechanism, and neither source establishes the sequence end to end.S1S2
Where the reasoning is carried by something unstated · 2
- Goal pillar. The pillar assumes that matching the induced response to available resources and actual need is a necessary design principle for obtaining the intended benefit.
- Gap question. Neither the preceding text nor the screened sources supplies evidence that the induced protection depends on glutamine moving from muscle to the protected tissue and being consumed there. Establish the missing link before relying on this step.
How a result here could mislead · 3
- Glutamine carrying a traceable isotope label, a distinguishable form of an atom, could reach the heart after administration into the circulation without having come from muscle. Release from a hind limb also does not by itself establish that muscle protein supplied the released glutamine. What closes it: The proposed joint measurements of limb release and heart uptake must account for blood flow and be combined with measurements of muscle protein breakdown and synthesis. Circulating label alone cannot establish the claimed source or muscle cost.
- Loss of protection after blocking GLS1 could be credited to loss of fuel even if glutamine instead protects against damaging oxidation, supports protein maintenance, or preserves cooperation among the cell’s energy-producing structures. What closes it: The proposed test must establish that ATP production falls before injury and that replacement fuel restores both energy production and protection while GLS1 remains blocked. Measurements must also distinguish these changes from the alternative protective processes described by the rivals; loss of protection alone does not separate them.
- A higher ATP amount after blocking glutamine use could be mistaken for improved energy provision, although the rival involving a local glutamine-recycling loop predicts that stopping ATP expenditure can raise ATP while removing protection. What closes it: ATP amount must be measured alongside its production and expenditure rates and heart injury or function. The interpretation must distinguish a larger stored amount from greater ongoing energy production.
What would make this wrong. The central fuel explanation would be contradicted if verified interruption of the heart’s use of glutamine-derived carbon left energy production and protection intact. It would also be contradicted if replacement fuel demonstrably restored energy production during continued GLS1 blockade but failed to restore protection, because energy provision would then be insufficient to explain the protective dependence. Separately, absence of net muscle protein loss across repeated responses would defeat the proposed muscle-depletion branch under the tested conditions.
What it would change. If the mechanism held, developing a life-extending fasting mimic would require accounting for the muscle resources that sustain its apparent heart benefit. Replacement fuel would become part of the proposed intervention, with repeated-cycle measurements needed to establish whether muscle rebuilding keeps pace with loss. Even successful tests in old mice and isolated hearts would not establish longer life, benefit in humans, or which replacement fuel and treatment schedule could preserve both tissues.
Sources read · 2
Aldometanib attenuates OGD/R-induced cardiomyocyte injury via mitigation of mitochondrial dysfunction. · Tissue & cell · 2026
“Mechanistically, our investigations revealed that aldometanib exerted a cardioprotective effect by alleviating cardiomyocyte damage through the regulation of mitochondrial function. Specifically, aldometanib enhanced mitophagy by activating lysosomal AMPK.”
Does not settle: The source does not establish PDZD8 phosphorylation, GLS1 activation, glutamine oxidation, skeletal-muscle-derived glutamine, delayed feeding, support of the tricarboxylic acid cycle or ATP production, muscle protein loss, loss of cardioprotection after disrupting this exchange, fuel replacement, longevity effects, or SPV_4. The reported cell experiments used H9c2 and AC16 cardiomyocyte lines, while the animal model details, treatment conditions, doses, and timescales are not provided in the retrieved text.
A combined 1H-NMR spectroscopy- and mass spectrometry-based metabolomic study of the PPAR-alpha null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome. · Physiological genomics · 2006
“Across all tissues, there was a profound decrease in glucose and a number of amino acids, including glutamine and alanine, and an increase in lactate, demonstrating that a failure to express PPAR-alpha results in perturbations in glycolysis, the citric acid cycle, and gluconeogenesis.”
Does not settle: Источник не устанавливает перенос глутамина из скелетных мышц в сердце, его окисление кардиомиоцитами, действие альдометаниба, участие AMPK, PDZD8 или GLS1, поддержку синтеза АТФ, кардиопротекцию либо истощение мышечного белка при повторном ответе.
The gap this hypothesis explains
Does copying early fasting preserve tissue energy using muscle fuel, with protection during delayed feeding requiring this transfer?
Original wording · exactly as the pipeline generated it
Может ли миметик раннего голодания сохранять энергию целевой ткани ценой расходования мышечного глутамина, и устраняет ли разрыв этого обмена защитный эффект при задержке питания?
What this question is asking
The question concerns whether a treatment that imitates the body's early response to going without food protects one tissue by drawing on fuel supplied by muscle. That fuel is glutamine, an amino acid that muscles produce and release and that other tissues can use. It asks whether the treatment preserves energy in the receiving tissue while feeding is delayed, compared with the same conditions without treatment. It then asks whether blocking the proposed glutamine transfer removes that protection compared with leaving the transfer intact. The treatment, receiving tissue, duration of the feeding delay and measures of energy and protection are unspecified; the proposed exchange is a possibility being questioned, rather than an established fact.
- Early fasting
- The initial period of going without food. The question gives no duration or specific bodily response that defines this period.
- Fasting mimetic
- A treatment intended to imitate some response to going without food. This names a proposed kind of intervention, not a specified substance or a demonstrated reproduction of every effect of fasting.
- Glutamine
- An amino acid, one of the substances used to make proteins, that also has other roles in the body. Here it is the proposed muscle-supplied fuel; S1 describes both its fuel role and its role in supporting production of genetic-information molecules.
- Skeletal muscle
- Muscle used to move and support the body. In this question it is the proposed source of glutamine supplied to another tissue.
- Receiving tissue
- The part of the body proposed to benefit from muscle-supplied glutamine. The question does not identify it, so the gut and kidney findings cannot automatically stand for the intended tissue.
- Tissue energy preservation
- Maintaining a tissue's available energy or ability to meet its energy needs. The question does not specify how this would be measured, and repair alone is not a stated measurement of it.
- Glutamine transfer
- The proposed passage of glutamine from muscle to a receiving tissue for use there. Increased release from muscle establishes only part of that proposed connection.
- Delayed feeding
- Food or nutritional supply arriving later than it otherwise would. Neither the length of the delay nor the feeding conditions are supplied.
- Protection
- A reduction in tissue harm or preservation of tissue function. The question does not define the outcome that would count as protection or establish that it is identical to maintaining energy.
- Ketone bodies
- A class of molecules the body can use as fuel during fasting. S2 examines elevated concentrations in relation to amino acid release from muscles of fasted birds.
- Alanine and glutamate
- Two amino acids involved in the muscle response described by S2. That source reports a shift away from alanine release and attributes increased glutamine production to greater glutamate availability.
- Glucocorticoids
- A class of hormones involved in responses to stress and regulation of how the body uses its resources. S3 describes them promoting protein breakdown, which increases muscle glutamine release.
- Protein breakdown
- The dismantling of proteins into smaller components, including amino acids. S3 places this process between the hormone response and increased glutamine supply for gut repair.
- Gut lining and immune cells
- The gut lining is the layer of cells facing the inside of the digestive tract; immune cells participate in the body's defenses. These are reported recipients or users of glutamine in S1 and S3.
- Dexamethasone
- A drug in the glucocorticoid class. S4 includes treatment with it among the settings associated with increased muscle glutamine release in sheep; the supplied material does not establish it as the fasting mimetic asked about.
- Energy is preserved, and blocking transfer removes protection Under this outcome, the treatment's benefit would depend on the muscle-to-tissue glutamine transfer under the conditions examined. Protection during delayed feeding would therefore require continued access to that supply, although a harmful cost to muscle would remain a separate question.
- Energy is preserved, but protection survives blocked transfer If the transfer were successfully blocked and protection remained, that transfer would not be necessary for the observed protection. Muscle glutamine release could accompany the treatment without explaining why the receiving tissue remains protected.
- The treatment does not preserve tissue energy The proposed energy benefit would not occur under the conditions examined. Even if muscle released more glutamine, that release would not establish the protective exchange described in the question.
Muscle-produced glutamine can supply fuel to cells lining internal surfaces and to immune cells, providing a reported starting point for the proposed connection between tissues [S1]. If a treatment preserves another tissue's energy by increasing its use of this supply, that benefit could depend on a continuing contribution from muscle. Increased glutamine release alone, however, would not establish either a damaging cost to muscle or protection of the receiving tissue. Mistaking release for demonstrated protection would overstate the evidence, while assuming protection is independent of muscle supply could conceal the dependency the question asks about.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Миметик раннего голодания сохраняет функцию целевой ткани благодаря окислению глутамина, поступающего из скелетных мышц. Проверяемый пример: альдометаниб активирует лизосомную АМФ-активируемую протеинкиназу (AMPK), а фосфорилирование белка PDZD8 повышает активность глутаминазы GLS1 в кардиомиоцитах. При задержке питания дополнительный углерод поддерживает цикл трикарбоновых кислот и образование аденозинтрифосфата (АТФ). Повторение этого ответа способно истощать мышечный белок, если его распад обеспечивает экспорт и превышает последующий синтез. Разрыв обмена тогда устраняет кардиопротекцию. Новый вариант миметика должен сочетать ранний сигнал голодания с замещением расходуемого топлива; его потенциальная польза для продолжительности жизни зависит от сохранения мышечного резерва. Стабилизируемое свойство: SPV_4.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
У старых мышей при задержке питания миметик увеличивает чистый выход глутамина из задней конечности и его углеродный вклад в окислительный обмен сердца. Избирательное подавление сердечной GLS1 снижает образование АТФ раньше появления повреждений и устраняет защиту. В изолированном сердце альтернативное окисляемое топливо восстанавливает защиту при сохранённой блокаде GLS1, если экспериментально подтверждено восстановление энергетического потока. При повторных циклах величина мышечной потери связана с интегральным экспортом и недостаточным восстановительным синтезом.
Would tell it apart from at least one rival. The prediction specifies directional changes, temporal ordering, loss and conditional restoration of protection, and an association across repeated cycles. These are measurable outcomes without numerical thresholds. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Доступны артериовенозные измерения с учётом кровотока, изотопные трассеры, перфузия сердца и индуцируемое тканевое подавление GLS1. Системное введение меченого глутамина само по себе не устанавливает мышечное происхождение: необходим совместный баланс конечности и сердца, дополненный оценкой синтеза и распада мышечного белка.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
У старых мышей при задержке питания миметик увеличивает чистый выход глутамина из задней конечности и его углеродный вклад в окислительный обмен сердца. Избирательное подавление сердечной GLS1 снижает образование АТФ раньше появления повреждений и устраняет защиту. В изолированном сердце альтернативное окисляемое топливо восстанавливает защиту при сохранённой блокаде GLS1, если экспериментально подтверждено восстановление энергетического потока. При повторных циклах величина мышечной потери связана с интегральным экспортом и недостаточным восстановительным синтезом.
- Rival 01 of 04What would separate them
Energy spending in the glutamine–glutamate cycle may protect the heart during fasting mimicry predicts: При неизменном поступлении глутамина и сохранённой GLS1 частичное подавление GLUL в кардиомиоцитах уменьшает встречные потоки синтеза и гидролиза глутамина, повышает отношение АТФ к аденозиндифосфату, но увеличивает восстановленность дыхательной цепи и устраняет защиту миметика. В клеточной модели регулируемая дополнительная АТФазная нагрузка восстанавливает защиту при сопоставимых аммиаке, глутатионе и гликозилировании. Простое энергетическое восполнение при отсутствии такого оборота защиты не возвращает.
- Rival 02 of 04What would separate them
Connected mitochondria may protect ageing heart cells when muscle glutamine supply falls predicts: При сопоставимых массе митохондрий, максимальной дыхательной мощности и доступности топлива зависимость функции сердца от ослабления GLS1 имеет порог, положение которого меняется при изменении связности сети. Увеличение связности сохраняет защиту после ослабления GLS1 при низком поступлении мышечного глутамина. Фрагментация отменяет этот эффект даже при восстановленных глутатионе и гексозаминовом обмене. Порог должен воспроизводиться при двух независимых способах изменения связности.
- Rival 03 of 04What would separate them
Muscle glutamine may protect the heart by supporting glutathione-dependent lipid peroxide removal predicts: После подавления сердечной GLS1 липидные перекиси растут раньше падения АТФ. В клеточной модели липроксстатин-1 либо подтверждённое восстановление внутриклеточного глутатиона возвращает защиту миметика при сохраняющемся снижении окисления глутамина. Альтернативное топливо, восстановившее энергетический поток, сохраняет недостаточную защиту. После обхода окислительного повреждения частичное подавление GLUL не должно воспроизводить обязательную потерю защиты, предсказанную another hypothesis of the same gap.
- Rival 04 of 04What would separate them
Muscle glutamine may protect the heart by supplying nitrogen for protein glycosylation predicts: Миметик увеличивает включение амидного 15N глутамина в гексозамины целевой ткани. Частичное подавление GFAT1 устраняет защиту при сохранённых АТФ и глутатионе. N-ацетилглюкозамин восстанавливает защиту и уменьшает потребность в поступающем глутамине только при работоспособном пути его повторного использования. Частичное подавление GLS1 сохраняет или усиливает защиту при доступном альтернативном топливе. Блокада использования N-ацетилглюкозамина отменяет специфическое восстановление.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.